464 related articles for article (PubMed ID: 18085440)
1. Recombinant human erythropoietin attenuates hepatic injury induced by ischemia/reperfusion in an isolated mouse liver model.
Hochhauser E; Pappo O; Ribakovsky E; Ravid A; Kurtzwald E; Cheporko Y; Lelchuk S; Ben-Ari Z
Apoptosis; 2008 Jan; 13(1):77-86. PubMed ID: 18085440
[TBL] [Abstract][Full Text] [Related]
2. The role of excessive versus acute administration of erythropoietin in attenuating hepatic ischemia-reperfusion injury.
Pappo O; Ben-Ari Z; Shevtsov E; Avlas O; Gassmann M; Ravid A; Cheporko Y; Hochhauser E
Can J Physiol Pharmacol; 2010 Dec; 88(12):1130-7. PubMed ID: 21164559
[TBL] [Abstract][Full Text] [Related]
3. Dual effect of erythropoietin on liver protection and regeneration after subtotal hepatectomy in rats.
Greif F; Ben-Ari Z; Taya R; Pappo O; Kurtzwald E; Cheporko Y; Ravid A; Hochhauser E
Liver Transpl; 2010 May; 16(5):631-8. PubMed ID: 20440772
[TBL] [Abstract][Full Text] [Related]
4. Effect of adenosine A2A receptor agonist (CGS) on ischemia/reperfusion injury in isolated rat liver.
Ben-Ari Z; Pappo O; Sulkes J; Cheporko Y; Vidne BA; Hochhauser E
Apoptosis; 2005 Oct; 10(5):955-62. PubMed ID: 16151631
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin B inactivation attenuates the apoptotic injury induced by ischemia/reperfusion of mouse liver.
Ben-Ari Z; Mor E; Azarov D; Sulkes J; Tor R; Cheporko Y; Hochhauser E; Pappo O
Apoptosis; 2005 Dec; 10(6):1261-9. PubMed ID: 16215674
[TBL] [Abstract][Full Text] [Related]
6. Uridine-5'-triphosphate protects against hepatic- ischemic/reperfusion injury in mice.
Ben-Ari Z; Pappo O; Yitzhaki S; Cheporko Y; Shainberg A; Zinman T; Ravid A; Zemel R; Bachmatov L; Kurtzwald E; Mor E; Hochhauser E
Transplantation; 2009 Apr; 87(8):1155-62. PubMed ID: 19384161
[TBL] [Abstract][Full Text] [Related]
7. Ischemic preconditioning attenuates morphological and biochemical changes in hepatic ischemia/reperfusion in rats.
Jin LM; Liu YX; Zhou L; Xie HY; Feng XW; Li H; Zheng SS
Pathobiology; 2010; 77(3):136-46. PubMed ID: 20516729
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production.
Mihov D; Bogdanov N; Grenacher B; Gassmann M; Zünd G; Bogdanova A; Tavakoli R
Eur J Cardiothorac Surg; 2009 May; 35(5):839-46; discussion 846. PubMed ID: 19237290
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin protects the liver from hepatic ischemia-reperfusion injury in the rat.
Sepodes B; Maio R; Pinto R; Sharples E; Oliveira P; McDonald M; Yaqoob M; Thiemermann C; Mota-Filipe H
Transpl Int; 2006 Nov; 19(11):919-26. PubMed ID: 17018128
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment with recombined human erythropoietin attenuates ischemia-reperfusion-induced lung injury in rats.
Wu H; Ren B; Zhu J; Dong G; Xu B; Wang C; Zheng X; Jing H
Eur J Cardiothorac Surg; 2006 Jun; 29(6):902-7. PubMed ID: 16675226
[TBL] [Abstract][Full Text] [Related]
11. JNK mediates hepatic ischemia reperfusion injury.
Uehara T; Bennett B; Sakata ST; Satoh Y; Bilter GK; Westwick JK; Brenner DA
J Hepatol; 2005 Jun; 42(6):850-9. PubMed ID: 15885356
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human erythropoietin pretreatment attenuates heart ischemia-reperfusion injury in rats by suppressing the systemic inflammatory response.
Shen Y; Wang Y; Li D; Wang C; Xu B; Dong G; Huang H; Jing H
Transplant Proc; 2010 Jun; 42(5):1595-7. PubMed ID: 20620481
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model.
Spandou E; Tsouchnikas I; Karkavelas G; Dounousi E; Simeonidou C; Guiba-Tziampiri O; Tsakiris D
Nephrol Dial Transplant; 2006 Feb; 21(2):330-6. PubMed ID: 16221709
[TBL] [Abstract][Full Text] [Related]
14. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
15. Akt activation protects rat liver from ischemia/reperfusion injury.
Harada N; Hatano E; Koizumi N; Nitta T; Yoshida M; Yamamoto N; Brenner DA; Yamaoka Y
J Surg Res; 2004 Oct; 121(2):159-70. PubMed ID: 15501455
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant erythropoietin on ischemia-reperfusion-induced apoptosis in rat liver.
Shawky HM; Younan SM; Rashed LA; Shoukry H
J Physiol Biochem; 2012 Mar; 68(1):19-28. PubMed ID: 21953513
[TBL] [Abstract][Full Text] [Related]
17. GdCl3 abates hepatic ischemia-reperfusion injury by inhibiting apoptosis in rats.
Li JY; Gu X; Zhang WH; Jia S; Zhou Y
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):518-23. PubMed ID: 19822496
[TBL] [Abstract][Full Text] [Related]
18. Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway.
Müller C; Dünschede F; Koch E; Vollmar AM; Kiemer AK
Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G769-78. PubMed ID: 12816756
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin-A does not prevent cold ischemia/reperfusion injury of rat livers.
Tarrab E; Huet PM; Brault A; Rocheleau B; Laurens M; Crenesse D
J Surg Res; 2012 Jun; 175(2):333-42. PubMed ID: 21696775
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of erythropoietin pretreatment in testicular ischemia-reperfusion injury in rats.
Ergur BU; Kiray M; Pekcetin C; Bagriyanik HA; Erbil G
J Pediatr Surg; 2008 Apr; 43(4):722-8. PubMed ID: 18405722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
